NPI registry status
Active
2026 NPPES data Obstetrics & Gynecology Physician NPI 1437210812 MD
Verify on CMS → Mimi Kang, MD
Obstetrics & Gynecology Physician in Mount Kisco, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 45,074 in Obstetrics & Gynecology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
500
Medicare Part D claims · 164 beneficiaries · Obstetrics & Gynecology Physician avg: 188
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.6/100
▲ 8 pts above national avg 83.5 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mimi Kang, MD reported a CMS MIPS final score of 91.6/100 - above the 83.5 national average - and filed 500 Medicare Part D claims in 2024.
- 91.6/100
- MIPS score · +8 vs avg
- 500
- Part D claims, 2024
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mimi Kang, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1437210812), first enumerated 12/12/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 500 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 91.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Mimi Kang, MD's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1437210812 · Obstetrics & Gynecology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ABOVE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1437210812
- ENUM-LEGACY 2006
- TAX-MID 45K Obstetrics &
- MIPS-ABOVE 91.6/100
- RX-LIGHT 500
- BOOK-LIGHT 3,105 in New York
- PHOTO-FINISH Emma Cermak · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Kang · this prov…
Kang · this provider
91.6 MIPS pts
- Jessica Goldberg…
Jessica Goldberger
91.6 MIPS pts
- Gary Willen · near
Gary Willen
91.6 MIPS pts
- Emma Cermak · near
Emma Cermak
91.6 MIPS pts
- Dale Wilmot · near
Dale Wilmot
91.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mimi Kang, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
92 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mimi Kang, MD sits
This provider among obstetrics & gynecology physician peers
Across the 7,360 obstetrics & gynecology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mimi Kang, MD writes more Part D claims than 93% of them and scores higher on MIPS quality than 68% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one obstetrics & gynecology physician peer from a representative sample of 60; the gold marker is Mimi Kang, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mimi Kang, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mimi Kang, MD?
High performer (top quartile)Primary specialty
Obstetrics & Gynecology Physician
Medicare Part D claims
500 166% vs specialty avg
MIPS final score
91.6/100 8.1 pts vs avg
Specialty distribution in New York
How Obstetrics & Gynecology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Mimi Kang, MD's 2023 MIPS final score plotted against the Obstetrics & Gynecology Physician national average
- MIPS Final Score
- 91.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1437210812 |
|---|---|
| Specialty | Obstetrics & Gynecology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 12/12/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.5824
Final Score
Measured-score avg: 83.5
90.0969
Quality
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mimi Kang, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Westchester Health Medical PC
Katonah, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Mimi Kang, MD. To verify Mimi Kang, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Mimi Kang, MD - brand share 14.0%
Obstetrics & Gynecology Physician average
14% brand-name claims vs 86% generic, on 500 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
500
Total Claims
$45K
Total Drug Cost
164
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 997.267
- Total Day Supply
- 27,297
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $19K
- Generic Drug Cost
- $26K
- Antibiotic Claims
- 22
Patient Demographics
- Average Patient Age
- 71.3 years
- Avg HCC Risk Score
- 0.73
- Gender Split
- 100% female / 0% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mimi Kang, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Estradiol
Estradiol
147 claims
- Clotrimazole-Betam… 38
Clotrimazole-Betamethasone
38 claims
- Progesterone 36
Progesterone
36 claims
- Yuvafem 34
Yuvafem
34 claims
- Estradiol (Twice W… 28
Estradiol (Twice Weekly)
28 claims
- Fluconazole 21
Fluconazole
21 claims
- Metronidazole 17
Metronidazole
17 claims
- Misoprostol 17
Misoprostol
17 claims
| Drug | Claims |
|---|---|
| Estradiol | 147 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 38 |
| Progesterone Progesterone, Micronized | 36 |
| Yuvafem Estradiol | 34 |
| Estradiol (Twice Weekly) Estradiol | 28 |
| Fluconazole | 21 |
| Metronidazole | 17 |
| Misoprostol | 17 |
| Valacyclovir Valacyclovir Hcl | 17 |
| Estring Estradiol | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Obstetrics & Gynecology Physician Overview
How Mimi Kang, MD fits within the Obstetrics & Gynecology Physician landscape nationally.
45,074
Obstetrics & Gynecology Physician Providers in US
56
States with Obstetrics & Gynecology Physician
188
Avg Claims per Provider
Mimi Kang, MD's 500 claims are above the specialty average of 188.
Nationwide Obstetrics & Gynecology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Kang, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.6 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Obstetrics & Gynecology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Kang.
One of 3,105 Obstetrics & Gynecology Physician providers enrolled in New York, 5 are shown here.
Dr. Gila Aaron
M.D.
New York, NY
Dr. David Abayev
D.O.
Rego Park, NY
Dr. Maria Abbattista
MD
Scarsdale, NY
Dr. Steven Abbey
MD
Buffalo, NY
Aiman Abboud
MD DO
Brooklyn, NY
Compare Obstetrics & Gynecology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mimi Kang, MD's specialty? ▼
Mimi Kang, MD specializes in Obstetrics & Gynecology Physician and practices in Mount Kisco, New York. Credentials: MD.
How much does Mimi Kang, MD prescribe under Medicare Part D? ▼
In 2024, Mimi Kang, MD wrote 500 Medicare Part D claims totaling $45K in drug costs for 164 beneficiaries.
What is Mimi Kang, MD's Medicare quality score? ▼
Mimi Kang, MD has a CMS MIPS Final Score of 91.6/100 (Quality: 90.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mimi Kang, MD located? ▼
Mimi Kang, MD is located at 105 S BEDFORD RD, Mount Kisco, NY, 10549. Phone: (914) 241-4900.
What is Mimi Kang, MD's NPI number? ▼
Mimi Kang, MD's National Provider Identifier (NPI) is 1437210812, issued on 12/12/2006.
Does Mimi Kang, MD prescribe more brand-name or generic drugs? ▼
Mimi Kang, MD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $19K in brand drug costs.
How many Obstetrics & Gynecology Physician providers are there in the US? ▼
There are 45,074 Obstetrics & Gynecology Physician providers across 56 states in the US. The average Obstetrics & Gynecology Physician provider writes 188 Medicare Part D claims per year.
What drugs does Mimi Kang, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Mimi Kang, MD's most frequently prescribed drugs include Estradiol, Clotrimazole-Betamethasone, Progesterone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mimi Kang, MD accept Medicare? ▼
Mimi Kang, MD appears in CMS Medicare data with 500 Part D claims and 164 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mimi Kang, MD's credentials? ▼
Mimi Kang, MD's NPI is 1437210812 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.